Grifols SA (GRFS) Earnings Date & Reports

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GRFS is expected to report earnings to rise 53.30% to 20 cents per share on July 29

Q2'25

Est.

$0.20

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.04

Q2'24

Est.

$0.09

The last earnings report on May 12 showed earnings per share of 13 cents, missing the estimate of 16 cents. With 266.48K shares outstanding, the current market capitalization sits at 5.48B.

View a ticker or compare two or three

Compare

GRFS